TrkAとは 意味・読み方・使い方

Use of an anti-NGF antibody capable of inhibiting the binding between NGF and TrkA, and capable of blocking the biological activity of TrkA is provided.例文帳に追加

NGFとTrkAとの間の結合を阻害することができ、TrkAの生物学的活性を阻止することができる抗NGF抗体の使用。 - 特許庁

PEPTIDE COMPOUND INHIBITING TRKA AND USE THEREOF例文帳に追加

ＴｒｋＡを阻害するペプチド化合物及びその用途 - 特許庁

To provide a low toxic tumor-therapeutic medicine using a peptide that suppresses TrkA activities.例文帳に追加

ＴｒｋＡ活性を抑制するペプチドを用いた、毒性の低い腫瘍治療薬を提供すること。 - 特許庁

MOLECULE THAT IS ABLE TO INHIBIT BINDING BETWEEN NGF AND TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT例文帳に追加

ＮＧＦとＴｒｋＡレセプターとの結合を阻害することができる、長期化作用を有する鎮痛剤としての分子 - 特許庁

To provide an agent acting based on an excellent action of inhibiting a trkA receptor and used for treating and/or preventing frequent urination, urinary urgency, and urinary incontinence involved in various lower urinary tract diseases including overactive bladder, various lower-urinary-tract-pain-accompanying lower urinary tract diseases such as interstitial cystitis and chronic prostatitis, and various pain-accompanying diseases.例文帳に追加

優れたtrkA 受容体阻害作用に基づく、過活動膀胱を含む各種下部尿路疾患に伴う頻尿、尿意切迫感、尿失禁、及び間質性膀胱炎や慢性前立腺炎などの下部尿路疼痛を伴う各種下部尿路疾患、並びに疼痛を伴う各種疾患の治療及び/又は予防剤を提供すること。 - 特許庁

Moreover, a second estimation drive torque calculation means S46 calculates second estimation drive torque TrkB based on delivery refrigerant pressure Pd and estimation drive torque determination means S47 to S49 define smaller one of TrkA and TrkB as estimation drive torque STrk.例文帳に追加

さらに、第２推定駆動トルク算出手段Ｓ４６が吐出冷媒圧力Ｐｄに基づいて第２推定駆動トルクＴｒｋＢを算出し、推定駆動トルク決定手段Ｓ４７〜Ｓ４９がＴｒｋＡおよびＴｒｋＢのうち小さい方の値を推定駆動トルクＳＴｒｋとする。 - 特許庁

A peptide compound is represented by formula (I): X-L-Y (wherein, X is a peptide residue having a function for promoting cell membrane permeability; L is a linker or peptide bond; Y has a function for inhibiting the tyrosine kinase activity of TrkA and is a peptide residue having 15 amino acid length or less containing the partial sequence of a specific amino acid sequence) or a pharmacologically acceptable salt thereof.例文帳に追加

式（Ｉ）：Ｘ−Ｌ−Ｙ（式中、Ｘは細胞膜透過性を促進する機能を有するペプチド残基であり、Ｌはリンカーまたはペプチド結合であり、ＹはＴｒｋＡのチロシンキナーゼ活性を抑制する機能を有し、且つ特定のアミノ酸配列の部分配列）を含む１５アミノ酸長以下のペプチド残基で表されるペプチド化合物または薬理学的に許容されるその塩。 - 特許庁